Cipher Pharmaceuticals Inc. EBITDA for the year ending December 31, 2024: USD 11.87 M

Cipher Pharmaceuticals Inc. EBITDA is USD 11.87 M for the year ending December 31, 2024, a 2.91% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Cipher Pharmaceuticals Inc. EBITDA for the year ending December 31, 2023 was USD 11.53 M, a -4.24% change year over year.
  • Cipher Pharmaceuticals Inc. EBITDA for the year ending December 31, 2022 was USD 12.04 M, a -11.86% change year over year.
  • Cipher Pharmaceuticals Inc. EBITDA for the year ending December 31, 2021 was USD 13.66 M, a 1.93% change year over year.
  • Cipher Pharmaceuticals Inc. EBITDA for the year ending December 31, 2020 was USD 13.40 M, a 4.14% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)